GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nipro Corp (TSE:8086) » Definitions » EV-to-Revenue

Nipro (TSE:8086) EV-to-Revenue : 1.32 (As of May. 11, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Nipro EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Nipro's enterprise value is 円764,340 Mil. Nipro's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was 円578,033 Mil. Therefore, Nipro's EV-to-Revenue for today is 1.32.

The historical rank and industry rank for Nipro's EV-to-Revenue or its related term are showing as below:

TSE:8086' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.31   Med: 1.55   Max: 2.15
Current: 1.32

During the past 13 years, the highest EV-to-Revenue of Nipro was 2.15. The lowest was 1.31. And the median was 1.55.

TSE:8086's EV-to-Revenue is ranked better than
77.24% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: 3.265 vs TSE:8086: 1.32

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-11), Nipro's stock price is 円1232.00. Nipro's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円3,140.55. Therefore, Nipro's PS Ratio for today is 0.39.


Nipro EV-to-Revenue Historical Data

The historical data trend for Nipro's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nipro EV-to-Revenue Chart

Nipro Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.54 1.50 1.51 1.32 1.32

Nipro Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.34 1.32 1.29 1.37 1.35

Competitive Comparison of Nipro's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, Nipro's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nipro's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nipro's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nipro's EV-to-Revenue falls into.



Nipro EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Nipro's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=764340.096/578033
=1.32

Nipro's current Enterprise Value is 円764,340 Mil.
Nipro's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円578,033 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nipro  (TSE:8086) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Nipro's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1232.00/3140.551
=0.39

Nipro's share price for today is 円1232.00.
Nipro's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円3,140.55.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nipro EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nipro's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Nipro (TSE:8086) Business Description

Traded in Other Exchanges
Address
3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

Nipro (TSE:8086) Headlines

No Headlines